At a pivotal time for the maturing – but still young – cryptocurrency industry, Foley & Lardner LLP surveyed executives and investors to gauge attitudes and perspectives on the use, risks and regulation of cryptocurrencies. The survey findings reveal that the vast majority of respondents believe the cryptocurrency industry should be regulated in the United States and that the industry does not have a well-grounded understanding of the application of existing regulation of financial markets and financial services. At the same time, while industry insiders are watching a range of potential risks – particularly related to hacking and security breaches – they expressed a willingness to take on risk for the opportunity to invest in or develop cryptocurrency businesses.
Download the Survey Report
View the Survey Press Release
Download the Survey Report
View the Survey Press Release
Author(s)
Related Insights
22 April 2025
Health Care Law Today
Health Care Marketing: The Seventh Circuit Addresses “Referrals” Under The Anti-Kickback Statute
The case, United States v. Sorenson, addressed whether a Medicare-registered distributor violated the AKS in making payments to advertising, marketing, and manufacturing companies that worked to sell orthopedic braces to Medicare patients. The court held that such payments were not “referrals” within the meaning of the AKS because the payments were made to entities that were neither physicians in a position to refer their patients nor other decisionmakers in positions to “leverage fluid, informal power and influence” over health care decisions.
22 April 2025
Health Care Law Today
Skilled Nursing Facilities: CMS Extends Medicare Revalidation Deadline
On April 17, 2025, the Centers for Medicare and Medicaid Services (CMS) announced another extension of the deadline by which skilled nursing facilities (SNFs) must revalidate their Medicare enrollments.
21 August 2025
Events
6th Clinical Trial Agreements Summit
Foley partners Monica Chmielewski, vice chair of the firm’s Health Care Practice Group, Kyle Faget, and Nate Beaver, co-chairs of the firm’s Medical Devices Area of Focus, are speaking at Dynamic Global Events’ 6th Clinical Trial Agreements (CTA) Summit on August 21-22.